SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · United Therapeutics shareholders approved the 2026 Stock Incentive Plan…

UNITED THERAPEUTICS Corp · 8-K filed Jun 29, 2026 at 16:32 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 29, 2026 at 16:32 ET

United Therapeutics shareholders approved the 2026 Stock Incentive Plan at the annual meeting, adding 1,500,000 new shares plus the remaining 2,413,730 shares from the prior plan to the equity compensation reserve. All 12 director nominees were elected, and the advisory say-on-pay resolution passed with 97% support. This is a routine governance filing with no material financial impact.

  • Shareholders approved the 2026 Stock Incentive Plan with 25,872,075 votes for and 10,070,290 against (72% of votes cast in favor).
  • The plan adds 1,500,000 new shares plus 2,413,730 shares remaining from the prior plan, with potential additional shares from forfeited awards.
  • All 12 director nominees were elected with strong support (lowest 'for' vote was 32,342,983 for Christopher Causey).
  • Advisory vote on executive compensation passed with 35,152,059 votes for (97% of votes cast).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access